Risedronate and white blood cell count decreased Patient Reports February 12, 2012

Risedronate Side Effects Report #4648698-7
Risedronate side effect was reported by a Physician from on Apr 13, 2005. Female patient, 60 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: large intestine carcinoma, white blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. Patient recovered.

Risedronate Side Effects Report #5003416-8
Risedronate side effect was reported by a Physician from JAPAN on Apr 26, 2006. Female patient, 54 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, ovarian cancer, uterine polyp, white blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. Patient recovered.

Risedronate Side Effects Report #5020725-7
Risedronate side effect was reported by a Physician from JAPAN on May 12, 2006. Female patient, 54 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, metrorrhagia, ovarian cancer, uterine polyp, white blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. Patient recovered.

Risedronate Side Effects Report #5142922-2
Risedronate side effect was reported by a Physician from JAPAN on Oct 20, 2006. Female patient, 35 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: blood creatinine decreased, granulocytopenia, white blood cell count decreased. Risedronate dosage: 2.5 MG, DAILY, ORAL. During the same period patient was treated with BONALON, FAMOTIDINE, PREDNISOLONE, SULFAMETHOXAZOLE, ALFAROL, PERSANTIN. Patient recovered.


Risedronate Side Effects Report #4939387-X
Risedronate side effect was reported by a Physician from JAPAN on Feb 20, 2006. Female patient, 24 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: granulocytopenia, white blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with STOGAR, PREDNISOLONE, ALFAROL, GASTROM. Patient recovered.

Risedronate Side Effects Report #5480260-9
Risedronate side effect was reported by a Physician from JAPAN on Sept 14, 2007. Male patient, 60 years of age, was treated with Risedronate. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.